-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
了概讓你輕鬆了解重要事件!
資料來源
-
疫苗作用
- 1. Vaccines and immunization
https://www.who.int/health-topics/vaccines-and-immunization#tab=tab_1
- 2. 消滅疾病,疫苗的發明與免疫反應
https://scitechvista.nat.gov.tw/c/s2GC.htm
- 3. 疫苗知多少?
https://taichung.tzuchi.com.tw/news/13/21/1086
- 4. 疫苗如何發揮作用:為什麼仍有人質疑它?
https://www.bbc.com/ukchina/trad/48682281#:~:text=1796%E5%B9%B4%EF%BC%8C%E8%A9%B9%E7%B4%8D%E5%9C%A8%E5%85%AB%E6%AD%B2%E7%9A%84%E5%85%92%E7%AB%A5%E8%A9%B9%E5%A7%86%E6%96%AF%C2%B7%E8%8F%B2%E6%99%AE%E6%96%AF%EF%BC%88James%20Phipps%EF%BC%89%E8%BA%AB%E4%B8%8A%E9%80%B2%E8%A1%8C%E4%BA%86%E4%B8%80%E5%80%8B%E5%AF%A6%E9%A9%97%E3%80%82
- 5. 為什麼要打疫苗?
https://www.narlabs.org.tw/xcscience/cont?xsmsid=0I148638629329404252&sid=0J198590395879580412
- 6. 疫苗功過知多少?
https://pansci.asia/archives/8842
- 7. 記憶性B細胞
https://zh.wikipedia.org/wiki/%E8%AE%B0%E5%BF%86B%E7%BB%86%E8%83%9E
- 1. Vaccines and immunization
-
疫苗研發過程
- 8. Spotlight on COVID-19: Vaccine development
https://www.invivogen.com/spotlight-covid-19-vaccine-development
- 9. Nonclinical evaluation of vaccines
https://www.who.int/biologicals/publications/trs/areas/vaccines/nonclinical_evaluation/en/
- 10. 我國新藥與疫苗研究開發、上市流程及相關法規之妥適性
https://dep.mohw.gov.tw/CLU/cp-619-8219-122.html
- 11. Clinical evaluation of vaccines
https://www.who.int/biologicals/vaccines/clinical_evaluation/en/
- 12. 疫苗研發臨床參考要點
https://www.cde.org.tw/Content/Files/Knowledge/64cb33f4-1e55-4d38-b527-f3fbb236e39b.pdf
- 13. 臨床試驗分期介紹
https://www.vghtc.gov.tw/UploadFiles/WebFiles/WebPagesFiles/Files/22b3f1f4-7acc-4206-97a4-d1c3773bae46/%E8%87%A8%E5%BA%8A%E8%A9%A6%E9%A9%97%E5%88%86%E6%9C%9F%E4%BB%8B%E7%B4%B9%EF%BC%9A%E7%AC%AC%E4%B8%80%E6%9C%9F%E8%87%B3%E7%AC%AC%E5%9B%9B%E6%9C%9F%E8%87%A8%E5%BA%8A%E8%A9%A6%E9%A9%97%E7%B0%A1%E4%BB%8B.pdf
- 14. Clinical evaluation of new vaccines
https://www.ema.europa.eu/en/clinical-evaluation-new-vaccines
- 15. 臨床試驗階段
https://tw.gsk.com/zh-tw/research/trials-in-people/clinical-trial-phase/
- 16. 臨床試驗介紹
https://www1.cgmh.org.tw/intr/intr2/c3s400/introduction.html
- 17. 目前研製伊波拉疫苗的進展?
https://www.cdc.gov.tw/Category/ListContent/4COwAvI-R5mMP_mH_DzeKQ?uaid=E1vbA6qByigRh4E38pXJeA
- 18. Draft landscape of COVID-19 candidate vaccines
https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
- 8. Spotlight on COVID-19: Vaccine development
-
新冠病毒疫苗研發近況
- 19. China’s coronavirus vaccines are leaping ahead – but face challenges as virus wanes
https://www.nature.com/articles/d41586-020-02244-1
- 20. The journey of developing a vaccine (Q&A)
https://www.eiu.com/n/?s=covid-19+vaccine&eiu_initial_search=1&nsi=a57b8966da
- 21. 撼動股價的 Moderna 新冠病毒 RNA 疫苗通過臨床一期測試,它成功上市的機率有多高?
https://pansci.asia/archives/188266
- 22. Pfizer mulling over COVID-19 R&D pact with BioNTech: report
https://www.fiercebiotech.com/biotech/pfizer-mulling-over-covid-19-r-d-pact-biontech-report
- 23. 燃燒吧,小宇宙!疫情之下,研發疫苗大絕招有哪些?
https://pansci.asia/archives/183449
- 24. 疫苗關鍵9問:關於疫苗,我們應該知道什麼?
https://www.commonhealth.com.tw/article/article.action?nid=82312
- 25. 開發疫苗大作戰:新型冠狀病毒疫苗有解了嗎?
https://pansci.asia/archives/178681
- 26. DNA 疫苗在傳染疾病領域的新發展
https://www.ssm.gov.mo/sssm/2011_no12_1/2011_no1_%203638.pdf
- 27. AstraZeneca 和牛津大學的新冠疫苗 1/2 期結果正面! 接種二劑 ChAdOx1 nCoV-19 皆產生中和抗體
https://geneonline.news/index.php/2020/07/21/phase-1-2-of-chadox1-ncov-19/?doing_wp_cron=1596713505.8496329784393310546875
- 28. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext
- 29. 抗冠疫苗早期人體數據正向?Pfizer 和 BioNTech 力拼下半年救世人?
https://geneonline.news/index.php/2020/07/02/pfizer-biontech-in-early-covid-19-vaccine-study/?doing_wp_cron=1596714179.1506979465484619140625
- 30. Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins
https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-phase-3-cove-study-mrna-vaccine-against-covid
- 31. Oxford COVID-19 vaccine to begin phase II/III human trials
https://www.ox.ac.uk/news/2020-05-22-oxford-covid-19-vaccine-begin-phase-iiiii-human-trials
- 32. 全球第一!俄羅斯研發出新冠疫苗 普亭女兒已接種
https://udn.com/news/story/120944/4773513?from=udn-catehotnews_ch2
- 19. China’s coronavirus vaccines are leaping ahead – but face challenges as virus wanes
-
基因疫苗
- 33. mRNA疫苗的好處
http://www.genetinfo.com/investment/featured/item/15156.html
- 34. A huge experiment’: How the world made so much progress on a Covid-19 vaccine so fast
https://www.statnews.com/2020/07/30/a-huge-experiment-how-the-world-made-so-much-progress-on-a-covid-19-vaccine-so-fast/
- 35. COVID-19 vaccine innovation could dramatically speed up worldwide production
https://medicalxpress.com/news/2020-07-covid-vaccine-worldwide-production.html
- 36. 打開新冠病毒的潘朵拉盒子
https://sa.ylib.com/MagArticle.aspx?Unit=featurearticles&id=4699
- 37. Getting to a COVID-19 vaccine as fast and as safely as possible
https://discoveries.childrenshospital.org/covid-19-vaccine/
- 38. Why a coronavirus vaccine takes over a year to produce – and why that is incredibly fast
https://www.weforum.org/agenda/2020/04/why-a-coronavirus-vaccine-takes-over-a-year-to-produce-and-why-that-is-incredibly-fast/
- 33. mRNA疫苗的好處
-
其他傳染病的資訊
- 39. 危機總動員:伊波拉病毒有疫苗了
https://opinion.cw.com.tw/blog/profile/195/article/9172
- 40. 伊波拉出血熱
https://zh.wikipedia.org/wiki/%E5%9F%83%E5%8D%9A%E6%8B%89%E5%87%BA%E8%A1%80%E7%83%AD
- 41. Severe acute respiratory syndrome(SARS)
https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome
- 42. Why a coronavirus vaccine could take way longer than a year
https://www.nationalgeographic.com/science/2020/04/why-coronavirus-vaccine-could-take-way-longer-than-a-year/
- 43. MERS
https://zh.wikipedia.org/wiki/%E4%B8%AD%E6%9D%B1%E5%91%BC%E5%90%B8%E7%B6%9C%E5%90%88%E7%97%87
- 39. 危機總動員:伊波拉病毒有疫苗了
-
疫苗預定帶來大筆資金
- 44. 歐美製藥大廠研發中疫苗 英國預訂9000萬劑
https://udn.com/news/story/120944/4716270
- 45. 美國已訂逾7億劑 各國搶購疫苗情況一覽
https://inews.hket.com/article/2714565/%E3%80%90%E6%96%B0%E5%86%A0%E7%96%AB%E8%8B%97%E3%80%91%E7%BE%8E%E5%9C%8B%E5%B7%B2%E8%A8%82%E9%80%BE7%E5%84%84%E5%8A%91%20%E5%90%84%E5%9C%8B%E6%90%B6%E8%B3%BC%E7%96%AB%E8%8B%97%E6%83%85%E6%B3%81%E4%B8%80%E8%A6%BD?mtc=20023
- 46. A Comprehensive COVID-19 Vaccine Plan
https://www.americanprogress.org/issues/healthcare/reports/2020/07/28/488196/comprehensive-covid-19-vaccine-plan/
- 47. UK increases COVID-19 vaccine manufacturing capacity
http://www.pharmatimes.com/news/uk_increases_covid-19_vaccine_manufacturing_capacity_1346214
- 44. 歐美製藥大廠研發中疫苗 英國預訂9000萬劑
-
快速研發的隱憂
- 48. Fast COVID-19 vaccine timelines are unrealistic and put the integrity of scientists at risk
https://theconversation.com/fast-covid-19-vaccine-timelines-are-unrealistic-and-put-the-integrity-of-scientists-at-risk-139824
- 49. The Risks of Rushing a COVID-19 Vaccine
https://www.scientificamerican.com/article/the-risks-of-rushing-a-covid-19-vaccine/
- 50. 《COVID-19疫苗》快速通關的新冠肺炎疫苗,有安全疑慮嗎?
http://www.genetinfo.com/international-news/item/40093.html
- 51. What are the risks of fast-tracking a Covid-19 vaccine?
https://www.chemistryworld.com/news/what-are-the-risks-of-fast-tracking-a-covid-19-vaccine/4012130.article
- 52. COVID-19 vaccines are on the fast-track to approval. How will we know they’re safe?
https://www.livescience.com/first-coronavirus-vaccine-safety.html
- 53. Fast COVID-19 vaccine timelines are unrealistic and put the integrity of scientists at risk
https://ovc.uoguelph.ca/news/fast-covid-19-vaccine-timelines-are-unrealistic-and-put-integrity-scientists-risk
- 54. The Risky Race for a Quick Coronavirus Vaccine
https://newrepublic.com/article/156932/risky-race-quick-coronavirus-vaccine
- 55. A COVID-19 vaccine won’t help if people don’t trust it
https://www.japantimes.co.jp/opinion/2020/08/01/commentary/world-commentary/covid-19-vaccine-wont-help-people-dont-trust/#.Xywx9BMzY1I
- 56. Russia’s approval of a COVID-19 vaccine is less than meets the press release
https://www.sciencemag.org/news/2020/08/russia-s-approval-covid-19-vaccine-less-meets-press-release
- 48. Fast COVID-19 vaccine timelines are unrealistic and put the integrity of scientists at risk
-